The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Fair Richard A.

Reporting owner CIK 0001695851 · PRESIDENT AND CEO · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Fair Richard A.Fair Richard A.Fair Richard A. · December 11, 2025 · Stock award · Stock Option (right to buy)Dec 11, 2025Dec 11, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

1 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 11, 2025Enliven Therapeutics, Inc.Stock Option (right to buy)Fair Richard A.Stock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Enliven Therapeutics, Inc.ELVN · company listings
Fair Richard A.PRESIDENT AND CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A875,0000Value: 0Currency not specifiedView ↗